2024-04-24 11:59:52 ET
More on Kuros Bioscience
Read the full article on Seeking Alpha
For further details see:
Kuros Bioscience reports Q1 resultshome / stock / csbtf / csbtf news
2024-04-24 11:59:52 ET
Read the full article on Seeking Alpha
For further details see:
Kuros Bioscience reports Q1 resultsMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Kuros Biosciences Ltd Company Name:
CSBTF Stock Symbol:
Market:
Financial Highlights Direct MagnetOs sales rose by 155% to CHF 13.9 million in Q1 2024 from CHF 5.4 million in Q1 2023; this corresponds to a sequential increase of 21.9% or CHF 2.5 million over Q4 2023 Total Kuros Medical Devices segment sales accelerated to CHF 13.9 million in Q1 202...
ZURICH, SWITZERLAND / ACCESSWIRE / April 17, 2024 / Kuros Biosciences (SIX:KURN), a leader in next generation bone graft technologies, held its Annual General Meeting today. The Annual General Meeting approved the Annual Report, the Annual Financial Statements, and the Consolidated Financial St...
Financial highlights Direct MagnetOs sales grew by 163% to CHF 31.7 million in 2023, climbing from CHF 12.1 million in 2022. Total medical device sales accelerated by 153% from CHF 13.3 million in 2022 to CHF 33.6 million in 2023 The Medical Devices segment achieved a positive EBITDA o...